Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 1, 2013, Pages 58-65

  Migliaretti, Giuseppe ^a   Berchialla, Paola ^a   Dalmasso, Paola ^a   Cavallo, Franco ^a   Chiò, Adriano ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Amyotrophic lateral sclerosis (ALS); Bayesian approach; Incidence; Spatial analysis

Indexed keywords

AGRICULTURAL CHEMICAL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DISEASE REGISTRY; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION PROCESSING; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RARE DISEASE; RURAL AREA; SPATIAL ANALYSIS; STANDARDIZED INCIDENCE RATIO;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BAYES THEOREM; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SPATIO-TEMPORAL ANALYSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84875409689     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2012.733401     Document Type: Article

References (35)

1. Chiò A, M agnani C, S chiffer D . A myotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study . Neurology. 1993; 43: 927-30.
2. Durrleman S, Alperovitch A . I ncreasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989; 39: 768-73.
3. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS) . Incidence of ALS in Italy: evidence for a uniform frequency in Western countries . Neurology. 2001; 56: 239-44.
4. Traynor BJ, C odd MB, C orr B, F orde C, F rost E, H ardiman O . Incidence and prevalence of ALS in Ireland, 1995-1997: a population based study . Neurology. 1999; 52: 504-9.
5. Bastos A F, O rsini M, M achado D, M ello MP, N ader S, S ilva JG, et al . Amyotrophic lateral sclerosis: one or multiple causes? Neurol Int. 2011; 3(1): e4.
6. Miranda ML, Alicia Overstreet Galeano M, T assone E, Allen KD, Horner RD . Spatial analysis of the aetiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans . Neurotoxicology. 2008; 29: 964-70.
7. Doi Y, Y okoyama T, T ango T, T akahashi K, F ujimoto K, Nakano I . Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995-2004 . J Neurol Sci. 2010; 298: 78-84.
8. Sabel CE, B oyle PJ, L ö y t ön en M, G atrell A C, J okelainen M, Flowerdew R, et al . Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death . Am J Epidemiol. 2003; 157: 898-905.
9. Turabelidze G, Z hu BP, S chootman M, M alone JL, H orowitz S, Weidinger J, et al . An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002 . Neurotoxicology. 2008; 29: 81-6.
10. Uccelli R, B inazzi A, Altavista P, B elli S, C omba P, Mastrantonio M, et al . Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data . Eur J Epidemiol. 2007; 22: 781-90.
11. Chiò A, M ora G, C alvo A, M azzini L, B ottacchi E, Mutani R, et al . Epidemiology of ALS in Italy: a 10-year prospective population based study . Neurology. 2009; 72: 725-31.
12. Brooks BR . E l Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ' Clinical limits of amyotrophic lateral sclerosis ' workshop contributors . J Neurol Sci. 1994; 124(Suppl): 96-107.
13. Banca Dati Demografi ca Evolutiva della Regione Piemonte (BDDE), http://www.regione.piemonte.it/stat/bdde/info/principi.htm.
14. StataCorp. S tatistical Software: Release 9. 0 . College Station, TX: Stata Corporation. 2005.
15. Besag J, Y ork J, M ollie A . B ayesian Image-Restoration, with two Applications in Spatial Statistics . Annals of the Institute of Statistical Mathematics. 1991; 43: 1-20.
16. S mith BJ . B OA: an R package for MCMC output convergence assessment and posterior inference . Journal of Statistical Software. 2007; 21: 1-37.
17. Cowles MK. P . M arkov chain Monte Carlo convergence diagnostics: a comparative review . Journal of the American Statistical Association. 1996; 91: 883-904.
18. Lunn DJ, T homas A, Best N, Spiegelhalter D . WinBUGS: a Bayesian modelling framework . Concepts, structure, and extensibility. Statistics and Computing. 2000; 10: 325-37.
19. Chiò A, B orghero G, P ugliatti M, T icca A, C alvo A, Moglia C, et al . Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene . Arch Neurol. 2011; 68: 594-8.
20. Armon C . A n evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis . Neuroepidemiology. 2003; 22: 217-28.
21. Chiò A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group . Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study . J Neurol Neurosurg Psychiatry. 2011; 82: 740-6.
22. Mitchell JD . A myotrophic lateral sclerosis: toxins and environment . Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 235-50.
23. Fernandez C, G reen P J . M odelling spatially correlated data via mixtures: a Bayesian approach . Journal of the Royal Statistical Society Series B-Statistical Methodology. 2002; 64: 805-26.
24. Lambert D . Z ero-Infl ated Poisson Regression, with an Application to Defects in Manufacturing . Technometrics. 1992; 34: 1-14.
25. Lawson AB, C lark A . S patial mixture relative risk models applied to disease mapping . Statistics in Medicine. 2002; 21: 359-70.
26. Banack SA, M urch SJ . M ultiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC . Amyotroph Lateral Scler. 2009; 10(Suppl 2): 34-40.
27. Bradley W G, M ash D C . B eyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases . Amyotroph Lateral Scler. 2009; 10 (Suppl 2): 7-20.
28. Morahan JM, P amphlett R . A myotrophic lateral sclerosis and exposure to environmental toxins: an Australian case control study . Neuroepidemiology. 2006; 27: 130-5.
29. Byrne S, W alsh C, L ynch C, B ede P, E lamin M, K enna K, et al . Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis . J Neurol Neurosurg Psychiatry. 2011; 82: 623-7.
30. Chiò A, B orghero G, R estagno G, M ora G, D repper C, Traynor BJ, et al . Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9orf72 . Brain. 2012; 135: 784-93.
31. Sabatelli M, C onforti FL, Z ollino M, M ora G, M onsurr ò MR, Volanti P, et al . C9orf72 hexanucleotide repeat expansions in the Italian sporadic ALS population . Neurobiol Aging. 2012; 33: 1848.e15-20.
32. Mok K, T raynor BJ, S chymick J, T ienari PJ, L aaksovirta H, Peuralinna T, et al . The chromosome 9 ALS and FTD locus is probably derived from a single founder . Neurobiology of Aging. 2012; 33: e3-8.
33. Forbes Colville S, P arratt J, S wingler RJ . T he incidence of motor neuron disease in Scotland . J Neurol. 2007; 254: 866-9.
34. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group . Incidence of ALS in Lombardy, Italy . Neurology. 2007; 68: 141-5.
35. Simpson CL, Al-Chalabi A . A myotrophic lateral sclerosis as a complex genetic disease . Biochimica Et Biophysica Acta-Molecular Basis of Disease. 2006; 1762: 973-85